164 related articles for article (PubMed ID: 27136097)
1. Pulchrin A, a New Natural Coumarin Derivative of Enicosanthellum pulchrum, Induces Apoptosis in Ovarian Cancer Cells via Intrinsic Pathway.
Nordin N; Fadaeinasab M; Mohan S; Mohd Hashim N; Othman R; Karimian H; Iman V; Ramli N; Mohd Ali H; Abdul Majid N
PLoS One; 2016; 11(5):e0154023. PubMed ID: 27136097
[TBL] [Abstract][Full Text] [Related]
2. Cleistopholine isolated from Enicosanthellum pulchrum exhibits apoptogenic properties in human ovarian cancer cells.
Nordin N; Majid NA; Mohan S; Dehghan F; Karimian H; Rahman MA; Ali HM; Hashim NM
Phytomedicine; 2016 Apr; 23(4):406-16. PubMed ID: 27002411
[TBL] [Abstract][Full Text] [Related]
3. Liriodenine, an aporphine alkaloid from Enicosanthellum pulchrum, inhibits proliferation of human ovarian cancer cells through induction of apoptosis via the mitochondrial signaling pathway and blocking cell cycle progression.
Nordin N; Majid NA; Hashim NM; Rahman MA; Hassan Z; Ali HM
Drug Des Devel Ther; 2015; 9():1437-48. PubMed ID: 25792804
[TBL] [Abstract][Full Text] [Related]
4. Plagioneurin B, a potent isolated compound induces apoptotic signalling pathways and cell cycle arrest in ovarian cancer cells.
Nordin N; Majid NA; Othman R; Omer FAA; Nasharuddin MNA; Hashim NM
Apoptosis; 2018 Feb; 23(2):152-169. PubMed ID: 29430581
[TBL] [Abstract][Full Text] [Related]
5. Dentatin isolated from Clausena excavata induces apoptosis in MCF-7 cells through the intrinsic pathway with involvement of NF-κB signalling and G0/G1 cell cycle arrest: a bioassay-guided approach.
Arbab IA; Abdul AB; Sukari MA; Abdullah R; Syam S; Kamalidehghan B; Ibrahim MY; Taha MM; Abdelwahab SI; Ali HM; Mohan S
J Ethnopharmacol; 2013 Jan; 145(1):343-54. PubMed ID: 23178663
[TBL] [Abstract][Full Text] [Related]
6. Time-dependent changes in factors involved in the apoptotic process in human ovarian cancer cells as a response to cisplatin.
Kolfschoten GM; Hulscher TM; Schrier SM; van Houten VM; Pinedo HM; Boven E
Gynecol Oncol; 2002 Mar; 84(3):404-12. PubMed ID: 11855878
[TBL] [Abstract][Full Text] [Related]
7. Oridonin effectively reverses cisplatin drug resistance in human ovarian cancer cells via induction of cell apoptosis and inhibition of matrix metalloproteinase expression.
Ma S; Tan W; Du B; Liu W; Li W; Che D; Zhang G
Mol Med Rep; 2016 Apr; 13(4):3342-8. PubMed ID: 26935490
[TBL] [Abstract][Full Text] [Related]
8. Anti-tumour activity of a novel coumarin-chalcone hybrid is mediated through intrinsic apoptotic pathway by inducing PUMA and altering Bax/Bcl-2 ratio.
Singh N; Sarkar J; Sashidhara KV; Ali S; Sinha S
Apoptosis; 2014 Jun; 19(6):1017-28. PubMed ID: 24638227
[TBL] [Abstract][Full Text] [Related]
9. Resistance to chemotherapy-induced apoptosis via decreased caspase-3 activity and overexpression of antiapoptotic proteins in ovarian cancer.
Yang X; Zheng F; Xing H; Gao Q; Wei W; Lu Y; Wang S; Zhou J; Hu W; Ma D
J Cancer Res Clin Oncol; 2004 Jul; 130(7):423-8. PubMed ID: 15156398
[TBL] [Abstract][Full Text] [Related]
10. Bcl-2 overexpression reduces cisplatin cytotoxicity by decreasing ER-mitochondrial Ca2+ signaling in SKOV3 cells.
Xu L; Xie Q; Qi L; Wang C; Xu N; Liu W; Yu Y; Li S; Xu Y
Oncol Rep; 2018 Mar; 39(3):985-992. PubMed ID: 29286126
[TBL] [Abstract][Full Text] [Related]
11. A novel chalcone derivative, LQFM064, induces breast cancer cells death via p53, p21, KIT and PDGFRA.
Cabral BLS; da Silva ACG; de Ávila RI; Cortez AP; Luzin RM; Lião LM; de Souza Gil E; Sanz G; Vaz BG; Sabino JR; Menegatti R; Valadares MC
Eur J Pharm Sci; 2017 Sep; 107():1-15. PubMed ID: 28627468
[TBL] [Abstract][Full Text] [Related]
12. New 6(17)-epoxylathyrane diterpene: aellinane from Euphorbia aellenii induces apoptosis via mitochondrial pathway in ovarian cancer cell line.
Nabatchian F; Moradi A; Aghaei M; Ghanadian M; Jafari SM; Tabesh S
Toxicol Mech Methods; 2017 Oct; 27(8):622-630. PubMed ID: 28651465
[TBL] [Abstract][Full Text] [Related]
13. Anticancer activity of a trans-platinum(II) complex of 3-aminoflavone to ovarian cancer cells.
Orzechowska M; Fabijańska M; Ochocki J; Małecki M
Ginekol Pol; 2017; 88(2):68-74. PubMed ID: 28326515
[TBL] [Abstract][Full Text] [Related]
14. Cisplatin inhibits paclitaxel-induced apoptosis in cisplatin-resistant ovarian cancer cell lines: possible explanation for failure of combination therapy.
Judson PL; Watson JM; Gehrig PA; Fowler WC; Haskill JS
Cancer Res; 1999 May; 59(10):2425-32. PubMed ID: 10344753
[TBL] [Abstract][Full Text] [Related]
15. Bcl-xL is expressed in ovarian carcinoma and modulates chemotherapy-induced apoptosis.
Liu JR; Fletcher B; Page C; Hu C; Nunez G; Baker V
Gynecol Oncol; 1998 Sep; 70(3):398-403. PubMed ID: 9790794
[TBL] [Abstract][Full Text] [Related]
16. The potent peptide antagonist to angiogenesis, C16Y, and cisplatin act synergistically in the down-regulation of the Bcl-2/Bax ratio and the induction of apoptosis in human ovarian cancer cells.
Shinagawa A; Yoshida Y; Kurokawa T; Horiuchi Y; Tsuyoshi H; Orisaka M; Sawamura Y; Kleinman HK; Kotsuji F
Int J Oncol; 2011 Dec; 39(6):1359-64. PubMed ID: 21935568
[TBL] [Abstract][Full Text] [Related]
17. Salinomycin induces apoptosis via death receptor-5 up-regulation in cisplatin-resistant ovarian cancer cells.
Parajuli B; Shin SJ; Kwon SH; Cha SD; Chung R; Park WJ; Lee HG; Cho CH
Anticancer Res; 2013 Apr; 33(4):1457-62. PubMed ID: 23564786
[TBL] [Abstract][Full Text] [Related]
18. Coumarin-based benzopyranone derivatives induced apoptosis in human lung (A549) cancer cells.
Musa MA; Badisa VL; Latinwo LM; Patterson TA; Owens MA
Anticancer Res; 2012 Oct; 32(10):4271-6. PubMed ID: 23060547
[TBL] [Abstract][Full Text] [Related]
19. Design and synthesis of new coumarin hybrids and insight into their mode of antiproliferative action.
Elshemy HAH; Zaki MA
Bioorg Med Chem; 2017 Feb; 25(3):1066-1075. PubMed ID: 28038941
[TBL] [Abstract][Full Text] [Related]
20. Absence of Bcl-xL down-regulation in response to cisplatin is associated with chemoresistance in ovarian carcinoma cells.
Villedieu M; Louis MH; Dutoit S; Brotin E; Lincet H; Duigou F; Staedel C; Gauduchon P; Poulain L
Gynecol Oncol; 2007 Apr; 105(1):31-44. PubMed ID: 17275076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
